Xtant Medical (XTNT) Stock: Buy, Sell, or Hold?
XTNT - Xtant Medical Holdings, Inc.
$0.36
-0.02 (-5.30%)
âŧ
5d:
+5.58%
30d:
+7.82%
90d:
-16.46%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When XTNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: XTNT is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: XTNT is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: XTNT is currently trading at $0.36, which is considered fair relative to its 30-day fair value range of $0.32 to $0.38. From a valuation perspective, the stock is trading at a discount (Forward PE: -11.9) compared to its historical average (65.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, XTNT is in a strong downtrend. Immediate support is located at $0.32, while resistance sits at $0.39. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: XTNT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.03 (+190.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XTNT is in a strong downtrend. Immediate support is located at $0.32, while resistance sits at $0.39. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: XTNT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.03 (+190.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.32 -
$0.38
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.3%)
- BULLISH: Trading 190.4% below Wall St target ($1.03)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 34/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.32 -
$0.38
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.32
Resistance Level
$0.39
Current Trend
Strong Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.86
Wall Street Target
$1.03
(+190.4%)
Revenue Growth (YoY)
-35.0%
Profit Margin
-10.2%
PE vs Historical
-11.9 vs 65.2
CHEAP
Share & Embed Analysis
Last updated: September 29, 2026 8:17 AM ET
Data refreshes hourly during market hours. Next update: 9:17 AM
Data refreshes hourly during market hours. Next update: 9:17 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTNT showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 72 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 44 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 55 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 54 HOLD |
